Minor amputation after revascularization in chronic limb-threatening ischemia: What is the optimal timing?

Abstract

Objectives

Patients with chronic limb-threatening ischemia (CLTI) have a high risk of lower limb amputation and loss of walking independence. Minor amputations play a key role in ensuring walking independence and they represent a challenge in terms of timing and level for vascular surgeons. A major cause of re-amputation is a defect in wound healing and a possible predictor of re-amputation for non-healing wounds could be the incorrect timing of minor amputation after revascularization. The lack of evidence in the literature leads to a wide variability of choices in clinical practice. The purpose of this study was to try to find the optimal timing analysing the risk of re-amputation in CLTI patients who have undergone successful revascularization and minor amputation focussing on timing of minor amputation.

Methods

We conducted a single centre retrospective analysis on a cohort of 151 patients consecutively admitted to our hospital for CLTI (Rutherford 5) between January 2014 and April 2022. All the enrolled patients underwent successful revascularization of lower limbs and a minor amputation for dry acral necrosis. The characteristics of the patients and the revascularization procedures were collected and analysed. Patients were divided into two groups based on the timing of minor amputation performed before (group 1) or after the day (group 2) that best predicts the risk of re-amputation according to a Receiver Operating Characteristic (ROC) curve analysis. The primary outcome of this study was the risk of re-amputation during the first 60 days of follow-up after a primary minor amputation, with revascularization still effective. The impact of the timing of minor amputation after revascularization, the type of revascularization and the presence of risk factors known to prolong the wound healing process were evaluated in a uni- and multi-variable logistic regression model.

Results

Systemic hypertension, and type of revascularization (i.e. open vs endovascular) were independent predictors of the risk of re-amputation at 60 days (HR 4.26, 95% CI 1.30–14.04, p = .017 and HR 2.35, 95% CI 1.16–4.78, p = .018, respectively). Moreover, time ≤14 days between revascularization and first amputation was associate with a clear, albeit not statistically significant, trend toward increased risk of re-amputation (HR 2.09, 95% CI 0.97–4.51, p = .06).

Conclusions

In a cohort of patients who underwent a successful revascularization for CLTI and a minor amputation for dry gangrene in the first 14 days after revascularization, a higher -although not significant-risk of re-amputation was reported. In this cohort of patients, a delayed demolitive procedure should be considered to allow better tissue perfusion and to reduce the risk of re-amputation.

Keywords

Amputation chronic limb-threatening ischemia revascularization time factor wound healing

Get full access to this article

View all access options for this article.

References

Conte

Bradbury

Kolh

GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery SVS, European Society for Vascular Surgery ESVS, and World Federation of Vascular Societies WFVS , et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1S):S1–S109. e33. Erratum in: Eur J Vasc Endovasc Surg. 2020 Mar;59(3):492-493. Erratum in: Eur J Vasc Endovasc Surg. 2020 Jul;60(1):158-159.

Setacci

Ricco

European Society for Vascular Surgery . Guidelines for critical limb ischaemia and diabetic foot-introduction. Eur J Vasc Endovasc Surg 2011; 42(Suppl 2): S1–S3.

Fowkes

Rudan

, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013; 382(9901): 1329–1340.

Tanda

Casula

Ruiu

, et al. Hospitalization rate and treatment strategy for critical limb ischemia in South Sardinia during Covid-19. Ital J Vasc Endovasc Surg 2022; 29(1): 7–10. DOI: 10.23736/S1824-4777.21.01527-8.

Biancari

. Meta-analysis of the prevalence, incidence and natural history of critical limb ischemia. J Cardiovasc Surg 2013; 54(6): 663–669.

Ziegler-Graham

MacKenzie

Ephraim

, et al. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil 2008; 89(3): 422–429.

Sheahan

Hamdan

Veraldi

, et al. Lower extremity minor amputations: the roles of diabetes mellitus and timing of revascularization. J Vasc Surg 2005; 42(3): 476–480.

Albrektsen

Henriksen

Holstein

. Minor amputations on the feet after revascularization for gangrene. A consecutive series of 95 limbs. Acta Orthop Scand 1997; 68(3): 291–293.

Steel

DeOrio

. Forefoot amputation with limb revascularization: the effects of amputation, timing, and wound closure on the peripheral vascular bypass graft site. Foot Ankle Int 2007; 28(6): 690–694.

10.

Azuma

Uchida

Kokubo

, et al.

Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery?

Eur J Vasc Endovasc Surg 2012; 43(3): 322–328.

11.

Dillingham

Pezzin

Shore

. Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations. Arch Phys Med Rehabil 2005; 86(3): 480–486.

12.

Beaulieu

Grimm

Lyu

, et al. Rates and predictors of readmission after minor lower extremity amputations. J Vasc Surg 2015; 62(1): 101–105.

13.

Chen

. Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: evidence from a cohort of a half-million diabetic patients. Diabetes Care 2006; 29(11): 2409–2414.

14.

Söderström

Arvela

Albäck

, et al. Healing of ischaemic tissue lesions after infrainguinal bypass surgery for critical leg ischaemia. Eur J Vasc Endovasc Surg 2008; 36(1): 90–95.

15.

Yang

Zhu

Han

, et al. Pathophysiology of peripheral arterial disease in diabetes mellitus. J Diabetes 2017; 9(2): 133–140.

16.

Chan

Montbriand

Eisenberg

, et al. Outcomes of minor amputations in patients with peripheral vascular disease over a 10-year period at a tertiary care institution. Vascular 2019; 27(1): 8–18.

17.

Morisaki

Matsuda

Matsubara

, et al. Editor’s choice - bypass surgery provides better wound healing than endovascular treatment in global limb anatomic staging system inframalleolar modifier P1. Eur J Vasc Endovasc Surg 2023; 65(5): 758–759. DOI: 10.1016/j.ejvs.2023.01.048.

18.

Farber

Menard

Conte

BEST-CLI Investigators , et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med 2022; 387: 2305–2316.

19.

Adam

Beard

Cleveland

BASIL trial participants , et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366(9501): 1925–1934.

20.

Bradbury

Moakes

Popplewell

BASIL-2 Investigators , et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet 2023; 401(10390): 1798–1809. DOI: 10.1016/S0140-6736(23)00462-2.